Home > Back to Publisher > Report Information

OTC Healthcare in Belgium to 2011

Datamonitor
July 31, 2008
190 Pages - SKU: DFMN1846326

Abstract Table of Contents Search inside this report Related Reports

Countries covered: Belgium

Introduction

This databook is a detailed information resource covering all the key data points on OTC Healthcare in Belgium. It includes comprehensive value volume segmentation and market share data. The databook supplies actual data to 2006 and full forecasts to 2011.

Scope

Contains information on:Analgesics,Cough & cold,Indigestion,Medicated skin products,Traditional medicines,Vitamins & Other OTC healthcare products
Provides market value, volume, expenditure and consumption data by market, segment and subsegment
Includes company and brand share data by categories

Highlights

The market for OTC Healthcare in Belgium increased between 2001-2006, growing at an average annual rate of 1.9%.

The leading company in the market in 2006 was Omega Pharma NV. The second-largest player was Novartis AG with Pfizer Inc in third place.

Reasons to Purchase

Discover the major quantitative trends affecting the OTC Healthcare markets
Understand consumers' consumption and expenditure patterns
Understand the future direction of the market with reliable historical data and full five year forecasting

Additional Information

Databooks are a detailed information resource covering all the key data points across all industry verticals. They provide data covering a particular market at country or regional level in comprehensive tabular and brief contextual format. The databook allows the user to study and analyze the data. This databook is comprised of an overview chapter covering the market as a whole, a chapter examining each category within the market, and a chapter containing socioeconomic analysis and data. It also includes a chapter detailing Datamonitor’s research methodology, and an appendix containing additional details.

Chapter 1 EXECUTIVE SUMMARY: Summary Market Level - OTC Healthcare; Summary category level - Analgesics; Summary category level - Cough and Cold Preparations; Summary category level - Traditional Medicines; Summary category level - First Aid Kits; Summary category level - Indigestion Preparations; Summary category level - Vitamins and Minerals; Summary category level - Plasters & Bandages; Summary category level - Medicated Skin Products; Summary category level - Other OTC Healthcare Products; Summary category level - Topical OTC Medicines
Chapter 2 INTRODUCTION: What is this report about?; How to use this report; Market Definition
Chapter 3 MARKET OVERVIEW: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 4 LEADING COMPANY PROFILES: Omega Pharma NV; Novartis AG
Chapter 5 CATEGORY ANALYSIS - ANALGESICS: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 6 CATEGORY ANALYSIS - COUGH AND COLD PREPARATIONS: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 7 CATEGORY ANALYSIS - TRADITIONAL MEDICINES: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 8 CATEGORY ANALYSIS - FIRST AID KITS: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 9 CATEGORY ANALYSIS - INDIGESTION PREPARATIONS: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 10 CATEGORY ANALYSIS - VITAMINS AND MINERALS: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 11 CATEGORY ANALYSIS - PLASTERS & BANDAGES: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 12 CATEGORY ANALYSIS - MEDICATED SKIN PRODUCTS: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 13 CATEGORY ANALYSIS - OTHER OTC HEALTHCARE PRODUCTS: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 14 CATEGORY ANALYSIS - TOPICAL OTC MEDICINES: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 15 COUNTRY COMPARISON: Value; Market Share
Chapter 16 NEW PRODUCT DEVELOPMENT: Product launches over time; Recent product launches
Chapter 17 BELGIUM SOCIOECONOMIC PROFILE: Country Overview; Key Facts; Political Overview; Belgium Economic Overview
Chapter 18 BELGIUM MACROECONOMIC PROFILE: Macroeconomic Indicators
Chapter 19 RESEARCH METHODOLOGY: Methodology overview; Secondary research; Market modelling; Primary research; Data finalisation; Ongoing research
Chapter 20 APPENDIX: Future readings; How to contact experts in your industry
LIST OF FIGURES: Figure 1: Belgium OTC Healthcare value & value forecast, 2001-2011 (EUR m, nominal prices); Figure 2: Belgium OTC Healthcare category growth comparison, by value, 2001-2011; Figure 3: Belgium OTC Healthcare company share, by value, 2005-2006 (%); Figure 4: Belgium Analgesics value & value forecast, 2001-2011 (EUR m, nominal prices); Figure 5: Belgium Analgesics category growth comparison, by value, 2001-2011; Figure 6: Belgium Analgesics company share, by value, 2005-2006 (%); Figure 7: Belgium Cough and Cold Preparations value & value forecast, 2001-2011 (EUR m, nominal prices); Figure 8: Belgium Cough and Cold Preparations category growth comparison, by value, 2001-2011; Figure 9: Belgium Cough and Cold Preparations company share, by value, 2005-2006 (%); Figure 10: Belgium Traditional Medicines value & value forecast, 2001-2011 (EUR m, nominal prices); Figure 11: Belgium Traditional Medicines company share, by value, 2005-2006 (%); Figure 12: Belgium First Aid Kits value & value forecast, 2001-2011 (EUR m, nominal prices); Figure 13: Belgium First Aid Kits company share, by value, 2005-2006 (%); Figure 14: Belgium Indigestion Preparations value & value forecast, 2001-2011 (EUR m, nominal prices); Figure 15: Belgium Indigestion Preparations category growth comparison, by value, 2001-2011; Figure 16: Belgium Indigestion Preparations company share, by value, 2005-2006 (%); Figure 17: Belgium Vitamins and Minerals value & value forecast, 2001-2011 (EUR m, nominal prices); Figure 18: Belgium Vitamins and Minerals category growth comparison, by value, 2001-2011; Figure 19: Belgium Vitamins and Minerals company share, by value, 2005-2006 (%); Figure 20: Belgium Plasters & Bandages value & value forecast, 2001-2011 (EUR m, nominal prices); Figure 21: Belgium Plasters & Bandages category growth comparison, by value, 2001-2011; Figure 22: Belgium Plasters & Bandages company share, by value, 2005-2006 (%); Figure 23: Belgium Medicated Skin Products value & value forecast, 2001-2011 (EUR m, nominal prices); Figure 24: Belgium Medicated Skin Products category growth comparison, by value, 2001-2011; Figure 25: Belgium Medicated Skin Products company share, by value, 2005-2006 (%); Figure 26: Belgium Other OTC Healthcare Products value & value forecast, 2001-2011 (EUR m, nominal prices); Figure 27: Belgium Other OTC Healthcare Products category growth comparison, by value, 2001-2011; Figure 28: Belgium Other OTC Healthcare Products company share, by value, 2005-2006 (%); Figure 29: Belgium Topical OTC Medicines value & value forecast, 2001-2011 (EUR m, nominal prices); Figure 30: Belgium Topical OTC Medicines category growth comparison, by value, 2001-2011; Figure 31: Belgium Topical OTC Medicines company share, by value, 2005-2006 (%); Figure 32: Global OTC Healthcare market split (value terms, 2006) - Top 5 countries; Figure 33: Global OTC Healthcare market value, 2001 - 2006 (Top 5 countries); Figure 34: Map of Belgium; Figure 35: Annual data review process
LIST OF TABLES: Table 1: OTC Healthcare category definitions; Table 2: Belgium OTC Healthcare value, 2001-2006 (EUR m, nominal prices); Table 3: Belgium OTC Healthcare value forecast, 2006-2011 (EUR m, nominal prices); Table 4: Belgium OTC Healthcare value, 2001-2006 (US$ m nominal prices); Table 5: Belgium OTC Healthcare value forecast, 2006-2011 (US$ m nominal prices); Table 6: Belgium OTC Healthcare brand share, by value, 2005-2006 (%); Table 7: Belgium OTC Healthcare value, by brand 2005-2006 (EUR m nominal prices); Table 8: Belgium OTC Healthcare company share by value, 2005-2006 (%); Table 9: Belgium OTC Healthcare value, by company, 2005-2006 (EUR m nominal prices); Table 10: Belgium OTC Healthcare expenditure per capita, 2001-2006 (EUR, nominal prices); Table 11: Belgium OTC Healthcare forecast expenditure per capita, 2006-2011 (EUR, nominal prices); Table 12: Belgium OTC Healthcare expenditure per capita, 2001-2006 (US$ nominal prices); Table 13: Belgium OTC Healthcare forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 14: Omega Pharma NV Key Facts; Table 15: Novartis AG Key Facts; Table 16: Belgium Analgesics value, 2001-2006 (EUR m, nominal prices); Table 17: Belgium Analgesics value forecast, 2006-2011 (EUR m, nominal prices); Table 18: Belgium Analgesics value, 2001-2006 (US$ m nominal prices); Table 19: Belgium Analgesics value forecast, 2006-2011 (US$ m nominal prices); Table 20: Belgium Analgesics brand share, by value, 2005-2006 (%); Table 21: Belgium Analgesics value, by brand 2005-2006 (EUR m nominal prices); Table 22: Belgium Analgesics company share by value, 2005-2006 (%); Table 23: Belgium Analgesics value, by company, 2005-2006 (EUR m nominal prices); Table 24: Belgium Analgesics expenditure per capita, 2001-2006 (EUR, nominal prices); Table 25: Belgium Analgesics forecast expenditure per capita, 2006-2011 (EUR, nominal prices); Table 26: Belgium Analgesics expenditure per capita, 2001-2006 (US$ nominal prices); Table 27: Belgium Analgesics forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 28: Belgium Cough and Cold Preparations value, 2001-2006 (EUR m, nominal prices); Table 29: Belgium Cough and Cold Preparations value forecast, 2006-2011 (EUR m, nominal prices); Table 30: Belgium Cough and Cold Preparations value, 2001-2006 (US$ m nominal prices); Table 31: Belgium Cough and Cold Preparations value forecast, 2006-2011 (US$ m nominal prices); Table 32: Belgium Cough and Cold Preparations brand share, by value, 2005-2006 (%); Table 33: Belgium Cough and Cold Preparations value, by brand 2005-2006 (EUR m nominal prices); Table 34: Belgium Cough and Cold Preparations company share by value, 2005-2006 (%); Table 35: Belgium Cough and Cold Preparations value, by company, 2005-2006 (EUR m nominal prices); Table 36: Belgium Cough and Cold Preparations expenditure per capita, 2001-2006 (EUR, nominal prices); Table 37: Belgium Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (EUR, nominal prices); Table 38: Belgium Cough and Cold Preparations expenditure per capita, 2001-2006 (US$ nominal prices); Table 39: Belgium Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 40: Belgium Traditional Medicines value, 2001-2006 (EUR m, nominal prices); Table 41: Belgium Traditional Medicines value forecast, 2006-2011 (EUR m, nominal prices); Table 42: Belgium Traditional Medicines value, 2001-2006 (US$ m nominal prices); Table 43: Belgium Traditional Medicines value forecast, 2006-2011 (US$ m nominal prices); Table 44: Belgium Traditional Medicines brand share, by value, 2005-2006 (%); Table 45: Belgium Traditional Medicines value, by brand 2005-2006 (EUR m nominal prices); Table 46: Belgium Traditional Medicines company share by value, 2005-2006 (%); Table 47: Belgium Traditional Medicines value, by company, 2005-2006 (EUR m nominal prices); Table 48: Belgium Traditional Medicines expenditure per capita, 2001-2006 (EUR, nominal prices); Table 49: Belgium Traditional Medicines forecast expenditure per capita, 2006-2011 (EUR, nominal prices); Table 50: Belgium Traditional Medicines expenditure per capita, 2001-2006 (US$ nominal prices); Table 51: Belgium Traditional Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 52: Belgium First Aid Kits value, 2001-2006 (EUR m, nominal prices); Table 53: Belgium First Aid Kits value forecast, 2006-2011 (EUR m, nominal prices); Table 54: Belgium First Aid Kits value, 2001-2006 (US$ m nominal prices); Table 55: Belgium First Aid Kits value forecast, 2006-2011 (US$ m nominal prices); Table 56: Belgium First Aid Kits brand share, by value, 2005-2006 (%); Table 57: Belgium First Aid Kits value, by brand 2005-2006 (EUR m nominal prices); Table 58: Belgium First Aid Kits company share by value, 2005-2006 (%); Table 59: Belgium First Aid Kits value, by company, 2005-2006 (EUR m nominal prices); Table 60: Belgium First Aid Kits expenditure per capita, 2001-2006 (EUR, nominal prices); Table 61: Belgium First Aid Kits forecast expenditure per capita, 2006-2011 (EUR, nominal prices); Table 62: Belgium First Aid Kits expenditure per capita, 2001-2006 (US$ nominal prices); Table 63: Belgium First Aid Kits forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 64: Belgium Indigestion Preparations value, 2001-2006 (EUR m, nominal prices); Table 65: Belgium Indigestion Preparations value forecast, 2006-2011 (EUR m, nominal prices); Table 66: Belgium Indigestion Preparations value, 2001-2006 (US$ m nominal prices); Table 67: Belgium Indigestion Preparations value forecast, 2006-2011 (US$ m nominal prices); Table 68: Belgium Indigestion Preparations brand share, by value, 2005-2006 (%); Table 69: Belgium Indigestion Preparations value, by brand 2005-2006 (EUR m nominal prices); Table 70: Belgium Indigestion Preparations company share by value, 2005-2006 (%); Table 71: Belgium Indigestion Preparations value, by company, 2005-2006 (EUR m nominal prices); Table 72: Belgium Indigestion Preparations expenditure per capita, 2001-2006 (EUR, nominal prices); Table 73: Belgium Indigestion Preparations forecast expenditure per capita, 2006-2011 (EUR, nominal prices); Table 74: Belgium Indigestion Preparations expenditure per capita, 2001-2006 (US$ nominal prices); Table 75: Belgium Indigestion Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 76: Belgium Vitamins and Minerals value, 2001-2006 (EUR m, nominal prices); Table 77: Belgium Vitamins and Minerals value forecast, 2006-2011 (EUR m, nominal prices); Table 78: Belgium Vitamins and Minerals value, 2001-2006 (US$ m nominal prices); Table 79: Belgium Vitamins and Minerals value forecast, 2006-2011 (US$ m nominal prices); Table 80: Belgium Vitamins and Minerals brand share, by value, 2005-2006 (%); Table 81: Belgium Vitamins and Minerals value, by brand 2005-2006 (EUR m nominal prices); Table 82: Belgium Vitamins and Minerals company share by value, 2005-2006 (%); Table 83: Belgium Vitamins and Minerals value, by company, 2005-2006 (EUR m nominal prices); Table 84: Belgium Vitamins and Minerals expenditure per capita, 2001-2006 (EUR, nominal prices); Table 85: Belgium Vitamins and Minerals forecast expenditure per capita, 2006-2011 (EUR, nominal prices); Table 86: Belgium Vitamins and Minerals expenditure per capita, 2001-2006 (US$ nominal prices); Table 87: Belgium Vitamins and Minerals forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 88: Belgium Plasters & Bandages value, 2001-2006 (EUR m, nominal prices); Table 89: Belgium Plasters & Bandages value forecast, 2006-2011 (EUR m, nominal prices); Table 90: Belgium Plasters & Bandages value, 2001-2006 (US$ m nominal prices); Table 91: Belgium Plasters & Bandages value forecast, 2006-2011 (US$ m nominal prices); Table 92: Belgium Plasters & Bandages brand share, by value, 2005-2006 (%); Table 93: Belgium Plasters & Bandages value, by brand 2005-2006 (EUR m nominal prices); Table 94: Belgium Plasters & Bandages company share by value, 2005-2006 (%); Table 95: Belgium Plasters & Bandages value, by company, 2005-2006 (EUR m nominal prices); Table 96: Belgium Plasters & Bandages expenditure per capita, 2001-2006 (EUR, nominal prices); Table 97: Belgium Plasters & Bandages forecast expenditure per capita, 2006-2011 (EUR, nominal prices); Table 98: Belgium Plasters & Bandages expenditure per capita, 2001-2006 (US$ nominal prices); Table 99: Belgium Plasters & Bandages forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 100: Belgium Medicated Skin Products value, 2001-2006 (EUR m, nominal prices); Table 101: Belgium Medicated Skin Products value forecast, 2006-2011 (EUR m, nominal prices); Table 102: Belgium Medicated Skin Products value, 2001-2006 (US$ m nominal prices); Table 103: Belgium Medicated Skin Products value forecast, 2006-2011 (US$ m nominal prices); Table 104: Belgium Medicated Skin Products brand share, by value, 2005-2006 (%); Table 105: Belgium Medicated Skin Products value, by brand 2005-2006 (EUR m nominal prices); Table 106: Belgium Medicated Skin Products company share by value, 2005-2006 (%); Table 107: Belgium Medicated Skin Products value, by company, 2005-2006 (EUR m nominal prices); Table 108: Belgium Medicated Skin Products expenditure per capita, 2001-2006 (EUR, nominal prices); Table 109: Belgium Medicated Skin Products forecast expenditure per capita, 2006-2011 (EUR, nominal prices); Table 110: Belgium Medicated Skin Products expenditure per capita, 2001-2006 (US$ nominal prices); Table 111: Belgium Medicated Skin Products forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 112: Belgium Other OTC Healthcare Products value, 2001-2006 (EUR m, nominal prices); Table 113: Belgium Other OTC Healthcare Products value forecast, 2006-2011 (EUR m, nominal prices); Table 114: Belgium Other OTC Healthcare Products value, 2001-2006 (US$ m nominal prices); Table 115: Belgium Other OTC Healthcare Products value forecast, 2006-2011 (US$ m nominal prices); Table 116: Belgium Other OTC Healthcare Products brand share, by value, 2005-2006 (%); Table 117: Belgium Other OTC Healthcare Products value, by brand 2005-2006 (EUR m nominal prices); Table 118: Belgium Other OTC Healthcare Products company share by value, 2005-2006 (%); Table 119: Belgium Other OTC Healthcare Products value, by company, 2005-2006 (EUR m nominal prices); Table 120: Belgium Other OTC Healthcare Products expenditure per capita, 2001-2006 (EUR, nominal prices); Table 121: Belgium Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (EUR, nominal prices); Table 122: Belgium Other OTC Healthcare Products expenditure per capita, 2001-2006 (US$ nominal prices); Table 123: Belgium Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 124: Belgium Topical OTC Medicines value, 2001-2006 (EUR m, nominal prices); Table 125: Belgium Topical OTC Medicines value forecast, 2006-2011 (EUR m, nominal prices); Table 126: Belgium Topical OTC Medicines value, 2001-2006 (US$ m nominal prices); Table 127: Belgium Topical OTC Medicines value forecast, 2006-2011 (US$ m nominal prices); Table 128: Belgium Topical OTC Medicines brand share, by value, 2005-2006 (%); Table 129: Belgium Topical OTC Medicines value, by brand 2005-2006 (EUR m nominal prices); Table 130: Belgium Topical OTC Medicines company share by value, 2005-2006 (%); Table 131: Belgium Topical OTC Medicines value, by company, 2005-2006 (EUR m nominal prices); Table 132: Belgium Topical OTC Medicines expenditure per capita, 2001-2006 (EUR, nominal prices); Table 133: Belgium Topical OTC Medicines forecast expenditure per capita, 2006-2011 (EUR, nominal prices); Table 134: Belgium Topical OTC Medicines expenditure per capita, 2001-2006 (US$ nominal prices); Table 135: Belgium Topical OTC Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 136: Global OTC Healthcare market value, 2006; Table 137: Global OTC Healthcare market split (value terms (US$ m), 2006) - Top 5 countries; Table 138: Leading players - Top 5 countries; Table 139: Belgium OTC Healthcare new product launches (reports) and SKUs, by company (Top 5 companies), 2006; Table 140: Belgium OTC Healthcare new product launches (reports), by flavor and fragrances 2006; Table 141: Belgium OTC Healthcare new product launches (reports), by Ingredients (Top 10 Ingredients), 2006; Table 142: Belgium OTC Healthcare new product launches (reports), by Package tags or Claims (Top 10 claims), 2006; Table 143: Belgium OTC Healthcare new product launches (reports) - Recent 5 launches; Table 144: Belgium Key Facts; Table 145: Belgium population, by age group, 2000-2005 (millions); Table 146: Belgium population forecast, by age group, 2005-2010 (millions); Table 147: Belgium population, by gender, 2000-2005 (millions); Table 148: Belgium population forecast, by gender, 2005-2010 (millions); Table 149: Belgium real GDP, 2000-2005 (EUR bn, 2005 prices); Table 150: Belgium real GDP forecast, 2005-2010 (EUR bn, 2005 prices); Table 151: Belgium nominal GDP, 2000-2005 (EUR bn, nominal prices); Table 152: Belgium real GDP, 2000-2005 (US$ bn, 2005 prices); Table 153: Belgium real GDP forecast, 2005-2010 (US$ bn, 2005 prices); Table 154: Belgium consumer price index, 2000-2005 (2000=100); Table 155: Belgium consumer price index, 2005-2010 (2000=100); Table 156: Belgium exchange rate, 2000-2005

More Belgium Over-the-Counter Drugs Reports

OTC Pharmaceuticals in Belgium by MarketLine
Introduction OTC Pharmaceuticals in Belgium industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2006-10, and forecast to ...

The Pharmaceutical Market: Belgium (pdf/xls) by Espicom Healthcare Intelligence
Espicom’s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of ...

Incontinence in Belgium by Euromonitor International
In 2010, incontinence products remained one of the main growth areas in tissue and hygiene in Belgium, achieving current value growth of 8%. Along with ...

NRT Smoking Cessation Aids in Belgium by Euromonitor International
Over the last couple of years anti-tobacco associations and manufacturers of NRT smoking cessation aids complained regarding the lack of significant measures against smoking. While ...

Medicated Skin Care in Belgium by Euromonitor International
Medicated skin care registered a downturn in demand in 2010. Sales seem to have been directly hit by the economic crisis and consumers subsequently watching ...

See all reports like this >>

More Belgium Reports

D&B Country RiskLine Report: Belgium by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

Retail Industry Logistics Spending in Belgium to 2014 by Datamonitor
Introduction This databook assesses the prospects for logistics in retail industry. It provides information on total logistics (by value) with respect to nature of sourcing and ...

D&B Country Report: Belgium by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Belgium: Country Profile by MarketLine
INTRODUCTION This report provides a detailed analysis on Belgium, providing an overview of its political, economic and business environments, represented in textual, graph and tabular formats. ...

2007 Belgium Industry & Market Outlook report by Barnes Reports
The 2007 Belgium Industry & Market Outlook report is the leading annual publication that describes over 100 major industries in Belgium and 500+ minor industries ...

See all reports like this >>

OTC Healthcare in Belgium to 2011

Share this report

Other tasks

Research Assistance

Related Markets

Over-the-Counter Drugs Reports

Free Alert Me service